Zacks: Analysts Expect CRH Medical Corporation (CRHM) Will Announce Quarterly Sales of $28.50 Million

Wall Street analysts expect that CRH Medical Corporation (NASDAQ:CRHM) will report $28.50 million in sales for the current fiscal quarter, Zacks Investment Research reports. Two analysts have made estimates for CRH Medical’s earnings, with the highest sales estimate coming in at $28.70 million and the lowest estimate coming in at $28.30 million. CRH Medical reported sales of $24.67 million in the same quarter last year, which indicates a positive year over year growth rate of 15.5%. The business is scheduled to issue its next quarterly earnings results on Monday, April 29th.

According to Zacks, analysts expect that CRH Medical will report full-year sales of $128.95 million for the current fiscal year, with estimates ranging from $125.45 million to $130.90 million. For the next financial year, analysts forecast that the firm will report sales of $143.17 million, with estimates ranging from $132.40 million to $158.00 million. Zacks Investment Research’s sales calculations are an average based on a survey of analysts that follow CRH Medical.

CRH Medical (NASDAQ:CRHM) last announced its quarterly earnings data on Wednesday, March 13th. The company reported $0.02 earnings per share for the quarter, meeting the Zacks’ consensus estimate of $0.02. The business had revenue of $32.02 million during the quarter, compared to analysts’ expectations of $31.40 million.

Separately, Clarus Securities reaffirmed a “buy” rating on shares of CRH Medical in a report on Wednesday, March 20th.

CRHM traded up $0.02 during trading on Tuesday, reaching $2.84. The company’s stock had a trading volume of 11,165 shares, compared to its average volume of 74,889. CRH Medical has a 52-week low of $2.51 and a 52-week high of $4.50.

CRH Medical Company Profile

CRH Medical Corporation provides various products and services to gastroenterologists for the treatment of gastrointestinal diseases in the United States, Canada, and internationally. It offers CRH O'Regan system, a single use, disposable, and hemorrhoid banding technology for treating various grades of hemorrhoid.

Further Reading: Balance Sheet

Get a free copy of the Zacks research report on CRH Medical (CRHM)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for CRH Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH Medical and related companies with's FREE daily email newsletter.